Analyst Ratings for [AMRX] Amneal Pharmaceuticals, Inc.

4/17/26	Initiated	Buy	X
AMRX Amneal Pharmaceuticals UBS
$19
12/9/25	Initiated	Overweight	X
AMRX Amneal Pharmaceuticals Barclays
$15
6/6/25	Initiated	Buy	X
AMRX Amneal Pharmaceuticals Goldman
$12
2/24/25	Upgrades	Neutral Overweight	X
AMRX Amneal Pharmaceuticals JP Morgan
$9 $12
9/6/24	Upgrades	Underweight Neutral	X
AMRX Amneal Pharmaceuticals JP Morgan
$9
4/7/21	Resumed	Sector Perform	X
AMRX Amneal Pharmaceuticals RBC Capital Mkts
$5
3/8/21	Upgrades	Sell Buy	X
AMRX Amneal Pharmaceuticals Goldman
$4 $6.50
7/22/19	Upgrades	Mkt Perform Outperform	X
AMRX Amneal Pharmaceuticals SVB Leerink
$11 $5
7/11/19	Downgrades	Outperform Sec Perform	X
AMRX Amneal Pharmaceuticals RBC Capital Mkts
$11 $6
7/8/19	Upgrades	Neutral Overweight	X
AMRX Amneal Pharmaceuticals Piper Jaffray
6/11/19	Initiated	Equal Weight	X
AMRX Amneal Pharmaceuticals Barclays
$9
5/21/19	Upgrades	Mkt Perform Strong Buy	X
AMRX Amneal Pharmaceuticals Raymond James
$13
3/20/19	Initiated	Buy	X
AMRX Amneal Pharmaceuticals SunTrust
$16
3/8/19	Downgrades	Outperform Mkt Perform	X
AMRX Amneal Pharmaceuticals SVB Leerink
$16 $12
12/14/18	Downgrades	Overweight Eq-Weight	X
AMRX Amneal Pharmaceuticals Morgan Stanley
10/16/18	Downgrades	Buy Hold	X
AMRX Amneal Pharmaceuticals SunTrust
8/13/18	Upgrades	Sec Perform Outperform	X
AMRX Amneal Pharmaceuticals RBC Capital Mkts
7/23/18	Initiated	Overweight	X
AMRX Amneal Pharmaceuticals Morgan Stanley
$22
6/22/18	Initiated	Buy	X
AMRX Amneal Pharmaceuticals B. Riley FBR, Inc.
$26
5/18/18	Initiated	Neutral	X
AMRX Amneal Pharmaceuticals JP Morgan

AMRX Amneal Pharmaceuticals, Inc.

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ

Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It also engages in the development, manufacture and sale of branded products. The company was founded in 2017 and is headquartered in Hayward, CA.